Komori
Share Issuance and Disposal3927Fuva Brain LimitedInformation and Communications, Services and Others

Notice Regarding the Finalization of the Terms of the Stock-Based Compensation Stock Options (Share Acquisition Rights)

The previously undetermined terms, including the issue price, have been finalized for the stock compensation-type stock options for directors approved on 24 June 2026. A total of 469 options, representing 46,900 underlying shares, will be allocated to 3 directors.

Worth reading
53Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
75700
¥ per stock acquisition right
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of stock compensation-type stock options (stock acquisition rights)

Who receives how much

46,900 common shares (469 share acquisition rights, 100 shares per right)

3 directors of the Company: 469 rights (46,900 shares)

The lower thin line represents the existing number of shares to which these shares will be added.

¥75,700 per share acquisition right (¥757 per share)
Amount of funds to be raised

Total payment amount: ¥35,507,300 (¥75,700 × 469 rights). However, as the amount will be offset against compensation receivables, estimated net proceeds: Not disclosed

Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total number issued: 469 rights. Remaining unexercised: Not disclosed
Categories and Number of Persons Covered
3 directors of the Company: 469 rights (46,900 shares)
Basis for determining the amount to be paid
Calculated using the Black-Scholes model on the allotment date, 16 July 2026. The periods used for the reference closing price and average share price, and the discount and premium rates: Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of stock compensation-type stock options (stock acquisition rights)
Number of shares to be issued or disposed of46,900 common shares (469 share acquisition rights, 100 shares per right)
Issue price and disposal price¥75,700 per share acquisition right (¥757 per share)
Amount of funds to be raisedTotal payment amount: ¥35,507,300 (¥75,700 × 469 rights). However, as the amount will be offset against compensation receivables, estimated net proceeds: Not disclosed
Intended allottee3 directors of the Company: 469 rights (46,900 shares)
Basis for determining the amount to be paidCalculated using the Black-Scholes model on the allotment date, 16 July 2026. The periods used for the reference closing price and average share price, and the discount and premium rates: Not disclosed
Number of Stock Acquisition RightsTotal number issued: 469 rights. Remaining unexercised: Not disclosed
Categories and Number of Persons Covered3 directors of the Company: 469 rights (46,900 shares)
Items this document does not state (20)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The options will be issued as stock compensation-type stock options pursuant to the resolution of the Board of Directors meeting held on 24 June 2026. The payment amount for the share acquisition rights was calculated using the Black-Scholes model, and the payment obligation will be offset against the compensation receivables of the eligible recipients.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Finalization of the Terms of the Stock-Based Compensation Stock Options (Share Acquisition Rights) | Fuva Brain Limited (3927) timely disclosure | Komori